Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Protein-based tissue adhesive reduces time to haemostasis in peripheral vascular surgery

View through CrossRef
Objectives The aim of this study was to evaluate the effectiveness of protein-based tissue adhesive (Bioglue ® ) in reducing time to haemostasis in patients undergoing peripheral vascular surgery. Methods From January to December 2021, 100 consecutive patients from 4 centres have been treated with open peripheral vascular surgery including upper and lower limb interventions. Patients have been allocated in each centre into control with no use of Bioglue ® ( Group no-Bio , 50 patients) or use of Bioglue ® ( Group Bio , 50 patients) by a block randomization method 10:10 until the required sample size was reached. Perioperative parameters including time to haemostasis, number of adjunctive stitches, and in-hospital bleeding have been analysed and compared in the two groups by means of mean independent-samples t T -test and Gehan–Breslow–Wilcoxon test. Results Both groups were homogeneous in terms of demographic data, preoperative risk factors, and preoperative medical therapy except for a higher percentage of active smokers in Group Bio (52% vs. 24%, p = 0.004). Femoral endarterectomy was most common in Group Bio (44% vs. 24%, p = 0.03), whilst the percentage of lower limb vein bypasses was higher in Group no-Bio (50% vs. 36%, p = 0.03). Bovine pericardium was the preferred material in Group Bio (20 cases, 40%), whilst autologous vein is mostly used in Group no-Bio (26 cases, 52%) ( p = 0.01). Time to haemostasis was faster in Group Bio (4.4 vs. 9.6 minutes, p < 0.001). The need for adjunctive stitches was higher in Group no-Bio (8 cases, 16%, Group Bio vs. 25 cases, 50%, Group no-Bio ; p < 0.001). The overall rate of in-hospital bleeding, including those requiring reintervention, was not different between the two groups (9 cases, 18%, Group Bio vs. 7 cases, 14%, Group no-Bio ; p = 0.39). Conclusions The protein-based tissue adhesive Bioglue ® reduced time to haemostasis and need for adjunctive stitches in peripheral vascular surgery. However, it did not affect the overall rate of perioperative bleedings. Further studies with larger sample sizes are needed to validate these outcomes.
Title: Protein-based tissue adhesive reduces time to haemostasis in peripheral vascular surgery
Description:
Objectives The aim of this study was to evaluate the effectiveness of protein-based tissue adhesive (Bioglue ® ) in reducing time to haemostasis in patients undergoing peripheral vascular surgery.
Methods From January to December 2021, 100 consecutive patients from 4 centres have been treated with open peripheral vascular surgery including upper and lower limb interventions.
Patients have been allocated in each centre into control with no use of Bioglue ® ( Group no-Bio , 50 patients) or use of Bioglue ® ( Group Bio , 50 patients) by a block randomization method 10:10 until the required sample size was reached.
Perioperative parameters including time to haemostasis, number of adjunctive stitches, and in-hospital bleeding have been analysed and compared in the two groups by means of mean independent-samples t T -test and Gehan–Breslow–Wilcoxon test.
Results Both groups were homogeneous in terms of demographic data, preoperative risk factors, and preoperative medical therapy except for a higher percentage of active smokers in Group Bio (52% vs.
24%, p = 0.
004).
Femoral endarterectomy was most common in Group Bio (44% vs.
24%, p = 0.
03), whilst the percentage of lower limb vein bypasses was higher in Group no-Bio (50% vs.
36%, p = 0.
03).
Bovine pericardium was the preferred material in Group Bio (20 cases, 40%), whilst autologous vein is mostly used in Group no-Bio (26 cases, 52%) ( p = 0.
01).
Time to haemostasis was faster in Group Bio (4.
4 vs.
9.
6 minutes, p < 0.
001).
The need for adjunctive stitches was higher in Group no-Bio (8 cases, 16%, Group Bio vs.
25 cases, 50%, Group no-Bio ; p < 0.
001).
The overall rate of in-hospital bleeding, including those requiring reintervention, was not different between the two groups (9 cases, 18%, Group Bio vs.
7 cases, 14%, Group no-Bio ; p = 0.
39).
Conclusions The protein-based tissue adhesive Bioglue ® reduced time to haemostasis and need for adjunctive stitches in peripheral vascular surgery.
However, it did not affect the overall rate of perioperative bleedings.
Further studies with larger sample sizes are needed to validate these outcomes.

Related Results

Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract Background Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
SUMMARY
SUMMARY
SUMMARYThe purpose of the present monograph is to give an account of the distribution of fibrinolytic components in the organism, with special reference to the tissue activator of ...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Correlation Between Hemoglobin A1c Levels and Incidence of Adhesive Capsulitis
Correlation Between Hemoglobin A1c Levels and Incidence of Adhesive Capsulitis
Abstract Background: Adhesive capsulitis, or arthrofibrosis, describes a pathological process in which the body forms excessive scar tissue or ad...
PTU-029 The Use Of Endoclot™ Therapy In The Endoscopic Management Of Gastrointestinal Bleeding
PTU-029 The Use Of Endoclot™ Therapy In The Endoscopic Management Of Gastrointestinal Bleeding
Introduction Endoclot™ is a non-toxic topical haemostatic powder consisting of absorbable modified polymers. We previously described our ...
Impact of a Peripheral Vascular Access Service on Device Use
Impact of a Peripheral Vascular Access Service on Device Use
Background More than 1 billion peripheral vascular access devices are inserted annually worldwide with potential complications including infection, thrombosis, an...

Back to Top